The role of tumor budding in the prognosis of patient with locally advanced colorectal cancer.

Research on the use of tumor budding (BD), an important survival marker for colorectal carcinoma (CRC), is still ongoing. In the present study, we aimed to determine the effectiveness of BD on prognosis in locally advanced CRC cases. In our study, CRC cases operated on between 2005 and 2015 were examined.BD was calculated using a standard methodology. A significant relationship was found between poor prognostic factors and BD (lymphatic invasion [p=0.008], tumor perforation [p=0.023], locally advanced-stage [p=0.023], positive surgical margins [p=0.005], advanced pT [p<0.001], and high grade [p<0.001]). Additionally, we found poor prognostic factors to be an independent risk factor in the regression analysis for BD (OS = 2.85 [1.15-3.48], p=0.001). Furthermore, correlation (r=0.695) and repeatability analysis (Kappa=0.56-0.75) for BD data indicated that it was successful (ROC: 10.23; AUC = 0.822 [0.714-0.943]). There was a significant difference in survival on univariate analysis for BD (RFS<0.001, OS = 0.001). In multivariate analysis, BD was shown to be an independent poor prognostic factor for CRC (RFS: HR = 2.96 [1.48-3.57], p<0001), and OS: HR = 2.69 [1.38-3.70], p<0.001). Our study indicates that BD detected using a standard methodology is a suitable predictive factor in determining poor prognosis in locally advanced CRC cases.